As of 2025-09-17, the Relative Valuation of Integra Lifesciences Holdings Corp (IART) is (98.95) USD. This relative valuation is based on P/E multiples. With the latest stock price at 14.83 USD, the upside of Integra Lifesciences Holdings Corp based on Relative Valuation is -767.2%.
The range of the Relative Valuation is (131.60) - 6.30 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.5x - 41.9x | 31.6x |
| Forward P/E multiples | 30.1x - 40.4x | 35.0x |
| Fair Price | (131.60) - 6.30 | (98.95) |
| Upside | -987.4% - -57.5% | -767.2% |
| Date | P/E |
| 2025-09-16 | -2.31 |
| 2025-09-15 | -2.35 |
| 2025-09-12 | -2.34 |
| 2025-09-11 | -2.41 |
| 2025-09-10 | -2.40 |
| 2025-09-09 | -2.40 |
| 2025-09-08 | -2.44 |
| 2025-09-05 | -2.49 |
| 2025-09-04 | -2.44 |
| 2025-09-03 | -2.35 |
| 2025-09-02 | -2.36 |
| 2025-08-29 | -2.35 |
| 2025-08-28 | -2.31 |
| 2025-08-27 | -2.31 |
| 2025-08-26 | -2.30 |
| 2025-08-25 | -2.22 |
| 2025-08-22 | -2.31 |
| 2025-08-21 | -2.13 |
| 2025-08-20 | -2.22 |
| 2025-08-19 | -2.29 |
| 2025-08-18 | -2.19 |
| 2025-08-15 | -2.21 |
| 2025-08-14 | -2.12 |
| 2025-08-13 | -2.20 |
| 2025-08-12 | -2.14 |
| 2025-08-11 | -1.98 |
| 2025-08-08 | -2.02 |
| 2025-08-07 | -1.97 |
| 2025-08-06 | -1.93 |
| 2025-08-05 | -1.98 |
| 2025-08-04 | -1.95 |
| 2025-08-01 | -1.92 |
| 2025-07-31 | -2.04 |
| 2025-07-30 | -1.93 |
| 2025-07-29 | -2.00 |
| 2025-07-28 | -2.04 |
| 2025-07-25 | -2.04 |
| 2025-07-24 | -1.98 |
| 2025-07-23 | -1.99 |
| 2025-07-22 | -1.88 |
| 2025-07-21 | -1.77 |
| 2025-07-18 | -1.73 |
| 2025-07-17 | -1.86 |
| 2025-07-16 | -1.88 |
| 2025-07-15 | -1.83 |
| 2025-07-14 | -1.90 |
| 2025-07-11 | -1.96 |
| 2025-07-10 | -2.05 |
| 2025-07-09 | -2.03 |
| 2025-07-08 | -2.02 |